Cargando…

Initial sirolimus dosage recommendations for pediatric patients with PIK3CD mutation-related immunodeficiency disease

Sirolimus is used to treat pediatric patients with PIK3CD mutation-related immunodeficiency disease. However, the initial dosages of sirolimus remain undecided. The present study aims to explore initial dosages in pediatric patients with PIK3CD mutation-related immunodeficiency disease. Pediatric pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiao, Wang, Jinglin, Lan, Jianger, Ge, Xilin, Xu, Hong, Zhang, Yu, Li, Zhiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515533/ https://www.ncbi.nlm.nih.gov/pubmed/36188573 http://dx.doi.org/10.3389/fphar.2022.919487

Ejemplares similares

Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex
por: Wang, Dong-Dong, et al.
Publicado: (2020)

Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
por: Chen, Xiao, et al.
Publicado: (2021)

Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations
por: Li, Zhi-ling, et al.
Publicado: (2018)

Population Pharmacokinetics and Initial Dose Optimization of Sirolimus Improving Drug Blood Level for Seizure Control in Pediatric Patients With Tuberous Sclerosis Complex
por: Chen, Xiao, et al.
Publicado: (2021)

Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus
por: Wang, Zuopeng, et al.
Publicado: (2023)

Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients
por: Liu, Xiao-Lin, et al.
Publicado: (2022)

Population pharmacokinetics of tacrolimus in pediatric patients with systemic-onset juvenile idiopathic arthritis: Initial dosage recommendations
por: Wang, Dongdong, et al.
Publicado: (2019)

Clinical and genetic analysis of immunodeficiency‐related diseases associated with PIK3CD mutations
por: Zhang, Qing, et al.
Publicado: (2019)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

Population pharmacokinetics and initial dose optimization of tacrolimus in children with severe combined immunodeficiency undergoing hematopoietic stem cell transplantation
por: Chen, Xiao, et al.
Publicado: (2022)

Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
por: Parker, Victoria E. R., et al.
Publicado: (2018)

Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
por: Eriksson, Per, et al.
Publicado: (2019)

Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin
por: Huang, Ying-Hua, et al.
Publicado: (2021)

Timing, Dosage, and Adherence of Antiretroviral Therapy and Risk of Osteoporosis in Patients With Human Immunodeficiency Virus Infection in Taiwan: A Nested Case-Control Study
por: Chiu, Mu-Lin, et al.
Publicado: (2021)

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment
por: Song, Xiangqing, et al.
Publicado: (2022)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer
por: Jung, Ki Sun, et al.
Publicado: (2017)

Immunodeficiency due to a novel variant in PIK3CD: a case report
por: Shashaani, Niloofar, et al.
Publicado: (2023)

Population pharmacokinetics of sirolimus in pediatric patients with kaposiform hemangioendothelioma: A retrospective study
por: Wang, Dongdong, et al.
Publicado: (2019)

Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoring
por: Shen, Guofang, et al.
Publicado: (2023)

Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation
por: Thian, Marini, et al.
Publicado: (2020)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

Initial dose recommendation for sirolimus in paediatric kaposiform haemangioendothelioma patients based on population pharmacokinetics and pharmacogenomics
por: Chen, Xiao, et al.
Publicado: (2020)

Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies
por: Zhao, Yue-Tao, et al.
Publicado: (2022)

Impact of Sampling Time Variability on Tacrolimus Dosage Regimen in Pediatric Primary Nephrotic Syndrome: Single-Center, Prospective, Observational Study
por: Huang, Lingfei, et al.
Publicado: (2022)

A mutation in PIK3CD gene causing pediatric systemic lupus erythematosus: A case report
por: Li, Guo-Min, et al.
Publicado: (2019)

AI Models to Assist Vancomycin Dosage Titration
por: Wang, Zhiyu, et al.
Publicado: (2022)

Effects of voriconazole on population pharmacokinetics and optimization of the initial dose of tacrolimus in children with chronic granulomatous disease undergoing hematopoietic stem cell transplantation
por: Chen, Xiao, et al.
Publicado: (2021)

Corrigendum: Impact of sampling time variability on tacrolimus dosage regimen in pediatric primary nephrotic syndrome: Single-center, prospective, observational study
por: Huang, Lingfei, et al.
Publicado: (2022)

Population Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Children after Renal Transplantation and Initial Dosage Recommendation Based on Body Surface Area
por: Wang, Guangfei, et al.
Publicado: (2022)

Initial dosage optimisation of cyclosporine in Chinese paediatric patients undergoing allogeneic haematopoietic stem cell transplantation based on population pharmacokinetics: a retrospective study
por: Feng, Huanwen, et al.
Publicado: (2023)

The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations
por: Yang, Qianting, et al.
Publicado: (2022)

Individualized antibiotic dosage regimens for patients with augmented renal clearance
por: Shi, A-Xi, et al.
Publicado: (2023)

Initial dosage optimization of ciclosporin in pediatric Chinese patients who underwent bone marrow transplants based on population pharmacokinetics
por: Chen, Xiao, et al.
Publicado: (2020)

Transcriptomics analysis of sirolimus treatment in lupus nephritis
por: Wang, Dongdong, et al.
Publicado: (2019)

Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
por: Yu, Lingyan, et al.
Publicado: (2023)

Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients
por: Requena-Méndez, Ana, et al.
Publicado: (2014)

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions
por: Gao, Liuliu, et al.
Publicado: (2020)

Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients
por: Li, Ying, et al.
Publicado: (2021)

Cardiotoxicity of Intravenously Administered CdSe/ZnS Quantum Dots in BALB/c Mice
por: Li, Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lofcvd9c8vskcns9nss2clkp3l